newsfilter
← Latest News
GlobeNewswire·

Celcuity Schedules Release of Third Quarter 2026 Financial Results and Webcast/Conference Call

MINNEAPOLIS, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC), a commercial-stage biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid